Romosozumab-aqqg and Zykadia

• Generic Name: romosozumab
• Dosage Forms: n.a.
• Other Brand Names: Evenity

Romosozumab-aqqg is a sclerostin inhibitor indicated for the treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy.

Limit duration of use to 12 monthly doses. If osteoporosis therapy remains warranted, continued therapy with an anti-resorptive agent should be considered.

• Generic Name: ceritinib
• Dosage Forms: capsule
• Other Brand Names: Zykadia

Zykadia (ceritinib) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Zykadia is used to treat non-small cell lung cancer that has spread to other parts of the body.

Zykadia is used only if your cancer has a specific genetic marker. Your doctor will test you for this gene.